Drug
Velafermin
Velafermin: highest development phase Phase 2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| velafermin NCT00323518 | Phase 2 | Oral Mucositis |
Latest
No recent events.
Follow Velafermin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.